You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 21, June 6, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  From the Centers for Disease Control and Prevention: Morbidity and Mortality Weekly Report
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Public Health and Injection Drug Use

JAMA. 2001;285:2706.

MMWR. 2001;50:377

This issue of MMWR focuses on injection drug use and highlights ways that state and local health departments monitor injection drug use-related health issues and develop interventions to prevent substance abuse and infections among injection drug users (IDUs). Substance abuse and addiction are major underlying causes of preventable morbidity and mortality in the United States.1 The risks increase when illicit substances are injected, which contributes to multiple health and social problems for IDUs, including transmission of bloodborne infections (e.g., human immunodeficiency virus [HIV] and hepatitis B and C infections) through sharing unsterile drug injection equipment and practicing unsafe sex.2 In the United States, approximately one third of acquired immunodeficiency syndrome cases3 and one half of new hepatitis C cases4 are associated with injection drug use. Fatal drug overdoses also contribute to death among IDUs.5 Although the number of persons who inject illicit drugs (primarily heroin, cocaine, and amphetamine) is not available, approximately one million persons in the United States are active IDUs.6


REFERENCES

1. McGinnis JM, Foege WH. Mortality and morbidity attributable to use of addictive substances in the United States. Proceedings of the Association of American Physicians. 1999;111:109-18. FULL TEXT | ISI | PUBMED
2. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993;119:1017-28. FREE FULL TEXT
3. CDC. HIV/AIDS surveillance report, 2000. Atlanta, Georgia. US Department of Health and Human Services, Public Health Service, CDC, 2000;12.
4. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S6-S10.
5. CDC. Unintentional opiate overdose deaths—King County, Washington, 1990-1999. MMWR Morb Mortal Wkly Rep. 2000;49:636-40. PUBMED
6. Gibbs DA, Hamill DN, Magruder-Habib K. Populations at increased risk of HIV infection: current knowledge and limitations. J Acquir Immune Defic Syndr. 1991;4:881-9.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.